Archivio Categoria: venture capital funding

Prolific Machines Raises $42M in Seed and Series A Funding

USA – Prolific Machines, a San Francisco, CA-based biotechnology company, raised $42M in Seed and Series A funding. Prolific’s first round was closed in late 2020, when SOSV’s IndieBio led their Pre-Seed round. The Seed round was led by Arvind Gupta at Mayfield. The Series A was led by Breakthrough Energy Ventures, with participation from […]

dope.security Raises $4M in Funding

USA – dope.security, a Mountain View, CA-based fly-direct Secure Web Gateway (SWG), raised $4M in funding. The round was led by boldstart ventures. boldstart General Partner Ed Sim and former Bluecoat and Symantec SVP Steven Schoenfeld are joining its Board of Directors.The company intends to use the funds to accelerate growth and expand operations.Led by […]

Chameleon Raises $13M in Series A Funding

USA – Chameleon, a San Francisco, CA-based provider of a product adoption platform for modern software companies, raised $13M in Series A funding. The round was led by Matrix Partners, with General Partner Ilya Sukhar joining the board of directors. Previous investor True Ventures and operators including Kevin Wang (SVP Product at Braze) and Kevin Mahaffey […]

SparingVision Raises €75M in Series B Funding

FRANCE – SparingVision, a French biotech company, raised €75m in Series B funding. The round was co-led by Jeito Capital and the University of Pittsburgh Medical Center Enterprise (UMPCE), with participation from Ysios Capital, 4Bio, Bpifrance and the RD Fund, the venture arm of Foundation Fighting Blindness (FFB). The company intends to use the funds […]

Bloom Community Raises $2.5M in Seed Funding

USA – Bloom Community, an Oakland, CA-based a safe digital space for sex-positive, queer, and edge-of-culture communities, raised $2.5M in Seed funding. The round was led by Tuesday Capital, with participation from YCombinator, Precursor Ventures, Behind Genius Ventures and angel investors like Claire Hughes Johnson and Nate Mitchell, as well as current and former Facebook […]

Candis Raises $16M in Funding 

GERMANY – Candis, a Berlin, Germany-based provider of a software solution for automating accounts payable processes, raised $16M in funding. The round, which brought total funding to $30m, was led by Viola FinTech, with participation from Lightspeed and Viola Ventures.The company intends to use the funds to launch credit cards which will provide a central […]

ff Venture Capital Launches US VC Fund Dedicated to Ukrainian Startups

UKRAINE – ff Venture Capital (ffVC), a NYC and Warsaw, Poland-based early-stage venture capital firm, has launched a US venture capital fund exclusively dedicated to Ukrainian founders and startups. Targeting $50mm, the ff Blue & Yellow Heritage Fund has received early commitments for $30m from institutional, family offices and corporate investors. With a signed memorandum with […]

MeWe Closes $27M Funding Round

USA – MeWe, a Los Angeles, CA-based privacy-first, social network committed to protecting user data, closed a $27m funding round. The round included $12m from previous investors and $15m in strategic financing from McCourt Global. The company intends to use the funds to optimize the benefits of social media, continue to uphold their commitment to reject financial models that exploit member […]

Kafene Raises $18M in Series B Funding

USA – Kafene, a New York-based fintech startup, raised $18M in Series B funding. The round was led by Third Prime and Valar Ventures. The company intends to use the funds to increase headcount and expand its business reach to meet the demand from merchants and consumers for omni-channel, technology-enabled purchase options.Led by CEO Neal […]

Whitelab Genomics Raises $10M in Series A Funding

FRANCE – Whitelab Genomics, a Paris, France- and Cambridge (MA)-based developer of genomics medicines via technology powered by artificial intelligence (AI), raised 10m in Series A funding. Backers included Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm, and Omnes Capital. The company intends to usr the funds for growth of R&D team […]